Recipient of federal assistance

SUNNYBROOK RESEARCH INSTITUTE

SUNNYBROOK RESEARCH INSTITUTE received $1.1M in federal grants and other assistance in FY2026, on 6 actions, +46% vs FY2025. It has no federal contracts in the loaded years. Since FY2021: $9M. Its largest awarding agency was National Institutes of Health ($1.1M).

Assistance · FY2026
$1.1M
New awards
0
Actions
6
Since FY2021
$9M
UEI
VFZHSP6WLZJ6
Other recipients
Open in the explorerFederal grants & assistance

Federal grants & assistance received

Grants, loans (counted at their subsidy cost), direct payments and insurance, by fiscal year of the action (USAspending.gov, FABS). Reported apart from contracts and never added to them.

Assistance by fiscal year

  1. 4.6MFY2021
  2. 1.2MFY2022
  3. -374.6KFY2023
  4. 1.7MFY2024
  5. 740.8KFY2025
  6. 1.1MFY2026

By type

  1. Grants$1.1M100%

Top programs · Awarding agencies

Obligations in FY2026.

Top programs

  1. 93.866 · Aging Research$565.2K52%
  2. 93.173 · Research Related to Deafness and Communication Disorders$517.2K48%
  3. 12.420 · Military Medical Research and Development-$1310.0%

Awarding agencies

  1. National Institutes of Health$1.1M100%
    Department of Health and Human Services

Largest awards

  1. THE DEVELOPMENT AND VALIDATION OF A NOVEL TOOL FOR THE ASSESSMENT OF BULBAR DYSFUNCTION IN ALS$3.6M
    93.173 · Research Related to Deafness and Communication Disorders· National Institutes of Health· Project grant· Jun 29, 2021 – Aug 24, 2026· R01DC017291
  2. IMAGING THE EFFECTS OF TRANSCRANIAL ALTERNATINGCURRENT STIMULATION IN AN EXPERIMENTAL MODEL OF ALZHEIMER'S DISEASE - PROJECT SUMMARY…$1.7M
    93.866 · Aging Research· National Institutes of Health· Project grant· Feb 20, 2024 – Mar 24, 2026· R01AG084681
  3. THE RELATIONSHIP BETWEEN TYPE OF OPIOID USED DURING CRITICAL ILLNESS AND TRANSITION TO CHRONIC PAIN$912.1K
    12.420 · Military Medical Research and Development· Defense Health Agency· Project grant· Aug 26, 2021 – Jul 28, 2026· W81XWH2110593
  4. PREDICTING SENSITIVITY TO DNA REPAIR INHIBITION IN SHORT-TERM PATIENT-DERIVED OVARIAN CANCER ORGANOIDS BEYOND PARP PROGRESSION$603.4K
    12.420 · Military Medical Research and Development· Defense Health Agency· Project grant· May 10, 2021 – Oct 17, 2025· W81XWH2110407

Subawards

Matched by Unique Entity ID: the first-tier subawards this organization reported as a prime recipient, and those primes reported paying it.

As a prime: who it pays · FY2026

No subawards reported as a prime in FY2026.

As a sub-recipient: who pays it · FY2026

  • Sub-grants: $350.6K (4 subawards)

4 primes

  1. UNIVERSITY OF ILLINOIS$156.8K45%
    URBANA, IL · 1 subaward
  2. THE UNIVERSITY OF CHICAGO$83K24%
    CHICAGO, IL · 1 subaward
  3. ECOG-ACRIN MEDICAL RESEARCH FOUNDATION, INC.$79.2K23%
    PHILADELPHIA, PA · 1 subaward
  4. TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA, THE$31.6K9.0%
    PHILADELPHIA, PA · 1 subaward

By fiscal year

  • FY2021: $0 paid out · $1.1M received
  • FY2022: $0 paid out · $1.5M received
  • FY2023: $0 paid out · $1.4M received
  • FY2024: $0 paid out · $1.1M received
  • FY2025: $0 paid out · $1.8M received
  • FY2026: $0 paid out · $350.6K received

Primes report first-tier subawards of $30,000 or more themselves, and many go unreported (GAO-24-106214). Reporting moved from FSRS to SAM.gov in March 2025 and fewer sub-contracts have been reported since. Amounts are what primes reported; they are never added to prime award totals.

Source: Subawards (first-tier sub-contracts and sub-grants reported under FFATA) (U.S. Department of the Treasury, USAspending.gov (reports filed in SAM.gov, formerly FSRS)), data current to Oct 10, 2026, loaded Oct 10, 2026 · Subawards loaded from FY2021.

Source: Federal financial assistance transactions (Financial Assistance Broker Submission) (U.S. Department of the Treasury, USAspending.gov), data current to Oct 10, 2026, loaded Oct 10, 2026 · FY2021–FY2026.